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ABSTRACT
....................................................................................................................................................
Objective To assess the public’s preferences regarding potential privacy threats from devices or services storing health-related personal data.
Materials and Methods A pan-European survey based on a stated-preference experiment for assessing preferences for electronic health data
storage, access, and sharing.
Results We obtained 20 882 survey responses (94 606 preferences) from 27 EU member countries. Respondents recognized the benefits of storing elec-
tronic health information, with 75.5%, 63.9%, and 58.9% agreeing that storage was important for improving treatment quality, preventing epidemics, and
reducing delays, respectively. Concerns about different levels of access by third parties were expressed by 48.9% to 60.6% of respondents.
On average, compared to devices or systems that only store basic health status information, respondents preferred devices that also store identifi-
cation data (coefficient/relative preference 95% CI¼ 0.04 [0.00-0.08], P¼ 0.034) and information on lifelong health conditions (coefficient¼ 0.13
[0.08 to 0.18], P< 0.001), but there was no evidence of this for devices with information on sensitive health conditions such as mental and sexual
health and addictions (coefficient¼0.03 [0.09 to 0.02], P¼ 0.24). Respondents were averse to their immediate family (coefficient¼0.05
[0.05 to 0.01], P¼ 0.011) and home care nurses (coefficient¼0.06 [0.11 to 0.02], P¼ 0.004) viewing this data, and strongly averse to
health insurance companies (coefficient¼0.43 [0.52 to 0.34], P< 0.001), private sector pharmaceutical companies (coefficient¼0.82
[0.99 to 0.64], P< 0.001), and academic researchers (coefficient¼0.53 [0.66 to 0.40], P< 0.001) viewing the data.
Conclusions Storing more detailed electronic health data was generally preferred, but respondents were averse to wider access to and sharing of
this information. When developing frameworks for the use of electronic health data, policy makers should consider approaches that both highlight
the benefits to the individual and minimize the perception of privacy risks.
....................................................................................................................................................
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BACKGROUND
The electronic storage, access, and sharing of medical data through
personal devices or systems of clinical electronic patient records un-
derpin current developments in record-keeping and communication
between patients and professionals,1 calculation of payments to health
care providers,2 measurement of health care quality,3 and patient en-
gagement with their health and health care, and they provide a re-
source for medical research.4–7 The scope and volume of information
stored has grown exponentially over the last 2 decades. Data sources
range from personal information uploaded voluntarily to personal de-
vices (eg, through smartphone apps8 or fitness gadgets) or websites
(eg, PatientsLikeMe in the United States or LifeSensor in Europe),9 or
in formal records of the clinical details of interactions with health ser-
vices (electronic patient records).1 Patient health records have evolved
from paper documents designed for record-keeping and communica-
tion between health care professionals, protected by doctor-patient
confidentiality, to electronic documents of which patients and doctors
are co-producers.1,5,7 In parallel, exploiting the economic potential of
health care data is becoming embedded into research and health ser-
vice strategies.5,6,10
Currently, the European Data Protection Directive11 is the overarch-
ing regulatory framework governing health care data in Europe; how-
ever, there is some divergence in EU countries as to how this directive
is applied in practice,12 and it is currently under review.13 Specific
guidance for storage, access to, and sharing of health data has been
slow to develop. This is partly because the speed of technological
change has outpaced law-making, but also because of the difficulties
of balancing the seemingly competing priorities of individual privacy of
health data against other priorities for the use of this data. No clear
consensus about how these priorities should be translated into law,
policy, and practice has yet emerged,14 although reviews are in prog-
ress.13,15,16 A recent UK information governance review acknowledges
this connection directly, that the duty to share information in patients’
wider interests is as important as the duty to maintain patient
confidentiality.15
Behind the need for policy guidance within the context of these
sometimes competing priorities is a need for clear, high-quality evi-
dence about what public preferences are for electronic health data,
and whether or how these public preferences illuminate trade-offs of
benefits and risks, between privacy and data storage, access, and
sharing.14,17,18 Research to date has been mixed, with conflicting find-
ings, highlighting both concern and support for sharing or use of medi-
cal records in research, for example.17,19–26
Stated preference (SP) experiments have been used extensively in
the fields of marketing, transport economics, environmental valuation,
health, and health care.27 Briefly, compared with opinion polls or tradi-
tional survey approaches, SP experiments provide a more nuanced in-
sight into preferences and allow a number of the attributes that may
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influence decision-making to be controlled for simultaneously. In an
SP experiment, respondents are asked to indicate the most preferred
alternative in a series of hypothetical scenarios which are often close
to real-life situations. Each alternative is described using multiple at-
tributes. Analysis of preferences from all respondents allows estima-
tion of relative preferences for each attribute and the values they take.
In this work we use this methodology to explore levels of privacy con-
cern across Europe and to describe European preferences regarding
devices or services storing health-related personal data empirically.
METHODS
Study participants
Participants were recruited as part of PACT: Public perception of secu-
rity and privacy: Assessing knowledge, Collecting evidence,
Translating research into action, a European Commission Seventh
Framework Programme funded research project. The project was de-
signed to assess public perceptions of security and privacy in 3 con-
texts: travel on metro or train, choice of Internet service provider, and
purchase of a device or service for storing health-related personal
data. Adults 18 and over were recruited from across the 27 European
Union (EU27) member states (this study was conceptualized in 2012,
before Croatia acceded).
Question development
The survey questionnaire and the SP experiment were developed
through literature review, focus groups (in the UK, Lithuania, and
Greece), and stakeholder consultation.18,28 The questionnaire included
4 sections: participants were asked about demographic information,
background on their own health status, attitudes toward data privacy,
and the SP scenarios. Cognitive testing was carried out in the UK,
Table 1: Respondent characteristics
Number of
respondents (%)
Survey mode Language(s) Number of
respondents (%)
All respondents 20 882 Country
Austria Online German 721 (3.5)
Gender Belgium Online French, Dutch 698 (3.4)
Male 9960 (47.7) Bulgaria Face-to-face Bulgarian 877 (4.2)
Female 10 922 (52.3) Cyprus Face-to-face Greek 577 (2.8)
Czech Republic Face-to-face Czech 757 (3.6)
Age Denmark Online Danish 744 (3.6)
18–24 2163 (10.4) Estonia Online Estonian 752 (3.6)
25–34 3512 (16.8) Finland Online Finnish 712 (3.4)
35–44 3719 (17.8) France Online French 730 (3.5)
45–54 3763 (18) Germany Mixed German 777 (3.7)
55–64 3735 (17.9) Greece Face-to-face Greek 880 (4.2)
65þ 3990 (19.1) Hungary Face-to-face Hungarian 831 (4.0)
Ireland Online English 696 (3.3)
Household income Italy Mixed Italian 784 (3.8)
<E500 3579 (17.1) Latvia Face-to-face Latvian, Russian 868 (4.2)
E500–E1500 6425 (30.8) Lithuania Face-to-face Lithuanian 1014 (4.9)
E1500–E3000 4444 (21.3) Luxembourg Online French, German, Luxembourgish 551 (2.6)
E3000–E9000 2846 (13.6) Malta Face-to-face Maltese 650 (3.1)
>E9000 160 (0.8) Netherlands Online Dutch 771 (3.7)
(Missing) 3428 (16.4) Poland Face-to-face Polish 863 (4.1)
Portugal Face-to-face Portuguese 901 (4.3)
Survey Approach Romania Face-to-face Romanian
Online 9198 (44.0) Slovakia Face-to-face Slovak 846 (4.1)
Offline 11684 (56.0) Slovenia Face-to-face Slovenian 885 (4.3)
Spain Online Spanish 685 (3.3)
Self-rated health Sweden Online Swedish 717 (3.4)
Good or very good 12823 (61.4) United Kingdom Online English 714 (3.4)
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Hungary, and Portugal once the first draft was finalized, focusing on
whether scenarios were understood by the respondents across the
European countries.29 Surveys were translated into the official lan-
guage(s) of each country (Table 1).
Demographic questions
Participants were asked their age in years, gender, and household in-
come (in 17 categories from <200 Euros to >12 000 Euros per month).
Privacy concerns
Respondents’ concern about privacy of information stored on a health
device was collected based on their responses about levels of concern
to the following three items: Personal information (name, address,
health conditions) accessed by non-medical personnel (eg, police); per-
sonal information (name, address, health conditions) accessed by pri-
vate companies (such as pharmaceutical and insurance companies);
misuse of personal information for harassment based on race, health
status, sexual orientation, etc., with 5-point Likert scale options ranging
from “not concerned at all” to “very concerned.” Additional questions
explored concerns about access to data and opinions of current levels
of health data security, with 5-point Likert-type responses ranging from
“agree strongly” to “disagree strongly.” Questions were developed from
existing tools, and18,30,31 full wording is given in the footnote to Table 2.
Stated-preference scenarios
The SP experiment was framed around the choice of a health data
storage device/system involving 5 attributes: the level of personal
health information stored, the authorities, and their geographical re-
gions, that can access the information, preferences for whom this
data can be shared with apart from medical personnel, and an
associated cost for using the device. Briefly, in a SP experiment, re-
spondents are asked to indicate the most preferred alternative in a se-
ries of hypothetical scenarios which are close to real-life situations.
Each alternative is described using a combination of options from mul-
tiple attributes, and an analysis of preferences from all respondents al-
lows estimation of relative preferences for each attribute and the
values it takes. Each attribute is described using a level in each choice
task; a full list of attributes and levels is given in Box 1 and an exam-
ple scenario is presented in Figure 1. In the design of the experiment,
out of all possible scenarios involving different combinations of all at-
tribute levels, 120 were selected, using the Ngene survey design soft-
ware.32 These 120 scenarios were chosen to reduce the standard
errors of estimated parameters. Each respondent considered 5 differ-
ent choices, between 2 of these scenarios.
Data collection
Data collection across the EU 27 countries was carried out by Ipsos, a
market research company. Online interviews were conducted in 12
countries (Table 1), using quota sampling for age, gender, and region
of residence within each country. Face-to-face interviews were con-
ducted in 13 countries with the lowest Internet access. In these 13
countries, areas were stratified by region and level of urbanization;
households were selected at random within each selected area; and
within each household 1 individual was sampled, with national quotas
for age and gender. In Germany and Italy, both survey modes were
used in order to allow for potential differences between survey
approaches to be accounted for at the analysis stage. Full sampling de-
tails are available.33 Pilot surveys were conducted in Denmark, Italy,
and Romania between May and July 2013. The main survey data col-
lection was carried out from August to November 2013. Respondents
were made aware of the data handling and anonymity protocols and
Table 2: Health and health data storage, privacy, and access attitudes and opinions
N Responses (%)
Attitudes to data storage
Storing health information is useful for improving treatment qualitya 20464 75.5 Agree or agree strongly
Storing health information is useful for preventing health epidemicsb 20361 63.9 Agree or agree strongly
Lack of personal and health information leads to delays in treatment in health emergenciesc 20368 58.9 Agree or agree strongly
Health providers collect too much personal informationd 20391 37.0 Agree or agree strongly
Concerns about access to data
Access to personal information by non-medical personnele 20696 48.9 Concerned or very concerned
Access to personal information by private companiese 20676 60.6 Concerned or very concerned
Misuse of personal information for harassmente 20572 54.5 Concerned or very concerned
Opinions about data security
Healthc are providers are successful in preventing unauthorized accessf 19372 38.4 Agree or agree strongly
Computer databases should be protected from unauthorized access, regardless of costg 20134 73.4 Agree or agree strongly
a“A system which stores health information (such as your blood group, allergies, and health conditions) can be useful in providing higher-quality
treatments”b“A system which stores health-related information (such as your blood group, allergies, and health conditions) can be useful in pre-
venting health epidemics (eg, H1N1/swine flu)”c“I am concerned that in a health emergency there could be an unacceptable delay due to the time
spent in identifying the person needing help and their health conditions before the treatment begins”d“I’m concerned that health care providers
(such as hospitals and health insurance companies) are collecting too much personal information about me” (Note: this is a negatively worded
question)eThese 3 items combine to form the “Health care privacy index”f“Health care providers (such as hospitals and health insurance compa-
nies) are successful in preventing unauthorized access to personal information”g“Computer databases that contain health information (including
health conditions, allergies, and identification) should be protected from unauthorized access no matter how much it costs”
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study purpose prior to the survey. Participation was voluntary; data col-
lection commenced only after obtaining individual informed consent.
Analysis
In order to describe variation in the levels of sensitivity to the privacy
of health care information across Europe, a composite measure of
concern for privacy of the information stored on the health device was
computed by country using Westin’s methodology.34 Using this
method, respondents were categorized into 3 groups, high, medium,
and low concerns, according to the number of “concerned/very con-
cerned” responses they gave to the 3 questions (Table 2).
The SPs were analyzed using a multinomial logit model (Box 2).
The model is based on the principle of Random Utility Maximization;
that is, a respondent chooses an alternative (among a set of available
alternatives) in order to maximize its “utility,” which represents the
satisfaction or benefit received by the person from the alternative.
Differences in preferences across countries were included by testing
whether each country required a separate coefficient in the model,
and using a similar approach, the effects of age, gender, and house-
hold income were included. Education level and employment status
were also considered, but there was no evidence that they improved
the fit of the model and hence they were not included in the final
analysis; only coefficients for country and socio-demographic charac-
teristics for each preference where P< 0.05 were retained. Country
scales were included to control for country-specific unobserved fac-
tors, and scales by survey methodology were included to control for
variation in response quality between the online and face-to-face sur-
veys. Bootstrap resampling was used to account for multiple prefer-
ence responses from each participant.35 Descriptive analysis was
carried out using SPSS 21,36 and the choice modeling analysis was
performed with ALOGIT 4.2.37
RESULTS
A total of 20 882 survey responses were obtained from 27 EU member
countries, with 551 to 1014 responses per country (Table 1).
Attitudes and privacy concerns
Overall, respondents recognized the benefits of storing electronic
health information, with 75.5%, 63.9%, and 58.9% of respondents
agreeing that storing electronic health data was important for improv-
ing treatment quality, preventing health epidemics, and reducing treat-
ment delays, respectively. However, between 48.9% and 60.6% of
respondents also expressed concerns about different levels of access
to this data, and only 38.4% of respondents agreed that health care
providers are currently successful in providing effective data security
(Table 2). Levels of health privacy concern varied strongly across
Europe (Figure 2). The highest proportions of respondents answering
“Not concerned at all” about privacy were observed in Sweden,
Slovenia, and Denmark, while the highest proportion of respondents
answering “Very concerned” was observed in Lithuania.
Preferences
Multinomial logit model estimates based on the SP data are presented
in Table 3 (baseline preferences across Europe) and Table 4 (country,
age, and gender-specific effects). The coefficients from SP models
capture the weight respondents placed on attribute levels. The coeffi-
cients thus represent the marginal utility of respondents’ gain or loss
(Box 2). In general, when coefficients are greater than zero, this
means that the attribute level is preferred relative to the reference
level (where the coefficient is set to zero) and it is seen as contributing
to service improvement or utility gain. Similarly, when coefficients are
less than zero, this means that respondents were “averse” to a partic-
ular option. For a given attribute, the relative size of coefficients can
also be compared. For example, a coefficient of 0.4 means that the
preference for a particular attribute level is twice as much as the pref-
erence for a level where the coefficient is 0.2 (ie, half the size) relative
to the reference level of that attribute; these coefficients are the
“betas” from Box 1. The coefficient for the cost is included in the
model as a continuous variable which describes the additional disutil-
ity of paying for the health device.
For each preference option, the country, age, and gender groups
presented in Table 4 were those where preferences were different
(P< 0.05) from the baseline across Europe. That is, in this table, posi-
tive coefficients for males indicate that preferences for the group were
more positive, or stronger, than for females across Europe.
Findings from 94 606 SPs from 20 882 survey respondents are
presented; 9804 out of 104 410 obtained responses were excluded,
because responses were missing or because the length of time taken
to respond to the scenario was below the minimum threshold (of less
than a minute in the case of the online survey).
Preferences for each attribute are summarized below.
Box 1: Attributes and levels used in the
SP experiment
What information is stored on the device/system?
Only basic health status information
Basic health status information
Identification
Lifelong health conditions
All other health conditions and medical history
Who can access the information?
Only doctors and nurses
Doctors, nurses, and emergency medical personnel
(paramedics)
Doctors, nurses, emergency medical personnel (paramedics),
and other non-medical emergency personnel (fire and rescue)
In which countries can your information can be accessed?
Only in [country of residence]
Across Europe (EU)
Worldwide
Who else can view this information apart from the medical
specialists?
No one
Immediate family
Nurses providing home care
Health insurance companies
Private sector pharmaceutical companies
Academic researchers (If your name is not connected to the
data)
Cost
Free (given by your hospital/national government)
0.5 E/month
1 E/month
2 E/month
3 E/month
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Storage: On average, compared to a device/system that “only
stores basic health status information,” respondents preferred health
devices that “also store identification data,” and “identification data
with information on lifelong health conditions,” coefficients: 0.04
(P¼ 0.034) and 0.13 (P< 0.001), respectively (Table 3). Respondents
disliked that devices store “additional information on all health condi-
tions (such as mental, sexual health, and addiction, etc.) and medical
history”; however, the aversion is not statistically significant, coeffi-
cient: 0.03 (P¼ 0.24). With very few exceptions (Czech Republic,
Lithuania, Cyprus, and UK), preferences are consistent across coun-
tries. Younger people aged 18 to 24 had consistently stronger
preferences for the storage of all 4 levels of information (coefficients:
from 0.10 to 0.42) compared with other age groups (Table 4).
Access: Across Europe, on average, respondents preferred that
“doctors, nurses, and paramedics” be able to access information,
when compared with “only doctors and nurses,” the reference level,
but were averse to emergency services additionally being able to ac-
cess the information, coefficients: 0.07 (P< 0.001) and 0.06
(P¼ 0.017), respectively. Older respondents (65 and over) had a
stronger aversion to widening the access to emergency services, coef-
ficient: 0.11 (P¼ 0.001). Further, with respect to geographic ac-
cess, respondents in general preferred that information be accessible
Figure 1: Stated preference experiment: Introductory text and example scenario presented to participants
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across the EU rather than their home country alone. However, they
were averse to widening the access beyond the EU (ie, worldwide ac-
cess). Again, older respondents (65 and over) preferred to limit access
to their home country when compared with other age groups.
Sharing: Respondents disliked “immediate family” and “nurses
providing home care” being able to access their health information,
coefficients: 0.05 (P¼ 0.011) and 0.06 (P¼ 0.004), respectively
(Table 3). They were very strongly averse to “health insurance compa-
nies” and “private sector pharmaceutical companies” being able to
view their health information, coefficients: 0.43 (P< .001) and
0.82 (P< .001). Respondents were also less likely to select “aca-
demic researchers” being able to view the information, even though in
this scenario the respondent’s name was not connected to the data
(ie, anonymous health information), coefficient: 0.53 (P< .001).
Cost: Respondents were sensitive to the additional cost per month
associated with the devices; people prefer not to pay, and if they have
to pay, they prefer a cheaper option. People from households with
lower incomes were more sensitive to price than those from house-
holds with high incomes. For example, households with an income of
<500 E/month were more sensitive to cost than households with in-
come >9000 E/month, coefficients: 0.0042 and 0.0016, respec-
tively. Respondents who declined to respond to the income question
were most cost sensitive, coefficient: 0.0044. Full multinomial logit
model outputs are available.38
DISCUSSION
We found that respondents across Europe preferred to store more,
rather than less, electronic health information and preferred access by
all health professionals, rather than just doctors and nurses. However,
wider access to include fire and rescue personnel (which may come
with higher risk to privacy) and anonymized sharing of this information
with academic researchers was not preferred, thus pointing toward a
preference for individual-level benefits over broader population-level
benefits. Respondents were also averse to sharing their health infor-
mation with other third parties, such as insurance providers and
pharmaceutical companies. Compared to limiting access in the coun-
try of residence, access across Europe was preferred, although access
worldwide was not. Findings were consistent across most countries in
Europe, which is surprising, particularly given country-specific differ-
ences including history, legal and political environment, and provision
of health care.12
Findings in the context of other research
The lack of consensus about public preferences for electronic data
storage, access, and sharing in previous research17,19–26 probably re-
flects in part the privacy valuation paradox18; that is, people value pri-
vacy very highly, but express differing preferences when it concerns
priorities that they deem important in the immediate context, usually
involving money or time, attitudes, and acceptability. The fact that, in
general, people have poor understanding of risk in decision-making
and a lack of knowledge about how electronic health data is used17,39
is also important. Previous work illustrates that in the context of elec-
tronic health data, people express “concerns” if asked about “con-
cerns” but are able to articulate benefits if asked about these.19 This
pattern is also reflected in our findings, which add additional robust,
empirical insight to these perceptions: respondents identify both the
benefits and risks to privacy of the storage of electronic health data;
however, the range of preferences identified in this work indicate that
respondents possess a nuanced understanding of privacy and are able
to understand both the risks to privacy and the benefits of electronic
health data storage.
Strengths and limitations
To our knowledge, this is the first Europe-wide SP study of this scale,
in this context; the methodological approach and findings presented
above are innovative and original. A second strength is the large sam-
ple size, allowing reliable estimates of preferences from across
Europe. Our finding that, with a few exceptions, preferences were con-
sistent across Europe strengthens the generalizability of this work be-
yond specific national contexts.
Box 2: Multinomial logit model specification
The responses to the SP exercises were modelled in a random utility theory framework using discrete choice models.
The overall utility of choice alternative i for respondent j is represented below:
Uij ¼ Vi j þ eij
Where Vij represents the deterministic or measurable part of the utility and eij is the error term, which represents the unobserved com-
ponent of the utility and is assumed to independent and identically distributed (iid) over all the alternatives and respondents. In this
study there are 3 alternatives: Alt A, Alt B, and “none of these,” and it is assumed that respondents choose the alternative which maxi-
mizes their utility. The distributional assumptions on eij give rise to different types of models. In case of a multinomial logit model, the
error term is assumed to follow a Type 1 extreme value distribution (Gumbel) and the resulting probabilities are shown below.
V Alt A½  ¼ b  XiA; P Alt A½  ¼ eV Alt A½ = eV½Alt A þ eV½Alt B þ eV½none
 
V Alt B½  ¼ b  XiB; P Alt A½  ¼ eV½Alt B= eV½Alt A þ eV½Alt B þ eV½none
 
V none½  ¼ bnone; P none½  ¼ eV½none= eV½Alt A þ eV½Alt B þ eV½none
 
Where b is the vector of parameters of the attributes and their levels, and XiA and XiB represent matrices of attributes and their levels
presented in each of the choice scenarios. The product of probabilities across all respondents is maximized (maximum likelihood
method) to estimate the vector of parameters.
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Missing data and refusal to participate are the main challenges to
any survey research of attitudes and preferences. In this research, not
responding to questions requiring personal information (eg, income) was
associated with a more risk-averse approach to electronic data storage
and access. We would also expect people who were more concerned
about data security to be underrepresented overall among respondents.
However, using an approach taken in other health survey contexts,40 by
having included “missing income” (representing a proxy for concerns
about data privacy and non-response) as a covariate in our choice
model, we partly accounted for this in the analysis.
Including attributes in the SP experiment relating to sharing of
non-anonymized data with health insurance companies and private
pharmaceutical companies, and sharing with academic researchers
with anonymization specifically articulated, means that preferences
across these 3 groups are less comparable. Nonetheless, they repre-
sent real-world situations in which electronic health data may be
shared, and the findings from this research provide insights into public
preferences across these scenarios.
A third limitation is that the time period for the main stage field-
work overlapped with publications in the news about US National
Security Agency and UK Government Communications Headquarters
surveillance practices revealed by Edward Snowden, which conceiv-
ably might have influenced some responses due to heightened aware-
ness of issues relating to privacy.
Figure 2: Levels of high health privacy concern across Europe
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Finally, some specific issues, such as attitudes toward linkage of
health data across multiple sources, were not explored.
SIGNIFICANCE
We now turn to a brief overview of the policy implications of each of
the findings.
Implications for policy: storage
In general, this research finds that the perceived benefits of storing
electronic health information outweigh the perceived risks to privacy
of storing any information at all. The massive shift to increased elec-
tronic storage of health information in the past 20 years is broadly in
line with public preferences.
However, this evidence also has specific implications for policy re-
garding the storage of sexual health data. We find that, although respon-
dents preferred storage of information on lifelong health conditions in
addition to basic health data (except among 18- to 34-year-olds), the
level “All health conditions: mental health, sexual health, addictions, and
medical history” was not preferred. In the UK, sexual health services are
not stored as part of a patient’s health record, and this approach has
been criticized for not enabling adequate information for performance
management of sexual health services.41 The findings presented here
provide some support for the current system of separation and anonymity
in the storage of sensitive medical records.
Implications for policy: access
One area where the findings from this work regarding access to data
are particularly relevant is in the development of frameworks for ac-
cess to European electronic health data worldwide. The recent memo-
randum of understanding which was signed by the US Department of
Health and Human Services and the UK Secretary of State for Health
paves the way for the sharing of electronic health data from the UK
outside Europe,42,43 and so it is particularly relevant to note that in this
work, access to information within Europe was preferred, but world-
wide access was not. Additionally, health information is increasingly
being accessed by the police and emergency services (to enable a
more effective response to emergencies) and we found in general that
this is not preferred.44
Implications for policy: sharing
Sharing of electronic health data beyond health care professionals
was not preferred. Our work, however, provides insight across several
areas in this ongoing debate, particularly around the sharing of elec-
tronic health data for research.
Not sharing data at all, or not sharing data without explicit individual
consent, is one approach. However, limitations to opt-in approaches to
data sharing have been highlighted, particularly gaming, by including a
simple tick box at the end of extensive terms and conditions, which are
typically not read or fully understood.45 Our finding that there are varia-
tions in preference between men and women and by age also high-
lights that if this approach were taken, it could not be expected that a
representative sample of records would be obtained.
Policy approaches to the sharing of electronic health data could
also learn from other sensitive methods used in medical research
where personal dislike of an approach (namely our finding that sharing
of electronic records for research is not preferred) is at odds with
broader research goals designed for the public good. For example,
there remains in the United States strong opposition to the use of em-
bryonic stem cells46 and, particularly in the 1980s and 1990s, there
was strong public opinion in the UK against the use of animals in re-
search.47 The poor understanding of animal research parallels the low
public knowledge of how electronic health information is used to-
day.19,47 It is perhaps relevant, therefore, that in this work the coun-
tries found to have the weakest aversion to the sharing of electronic
health data for research were Estonia and Denmark. Denmark in par-
ticular has a long history of using population databases in medical re-
search, and Estonia has developed a high-profile national genetic
database in the past 15 years and is a renowned leader in digitization
of many societal functions. It is possible that, over time, as electronic
data health research becomes more established, aversion to this use
of health data may tail off. Although options for data sharing may not
be preferred, in some situations they may become acceptable.45
Strong regulatory frameworks, however, have also been part of the
national policy landscape governing both animal and embryonic stem
Table 3: Stated preference choice modelling results of pref-
erences across Europe (baseline group)a
Model parameter Coefficient (preference) P-value
Information stored
Basic health status Reference
[information above þ] identification 0.04 (0.00–0.08) 0.34
[information above þ] lifelong health
conditions
0.13 (0.08–0.18) <.001
[information above þ] all other health
conditions and medical history
0.03 (0.09 to 0.02) 0.24
Access (personnel)
Only doctors and nurses Reference
Doctors, nurses, and paramedics 0.07 (0.04 to 0.10) <.001
Doctors, nurses, paramedics, and fire
and rescue
0.06 (0.11 to 0.01) 0.17
Access (location)
Only in the home country Reference
Across Europe (EU) 0.06 (0.02 to 0.10) 0.02
Worldwide 0.14 (0.19 to 0.09) <.001
Sharing
No one Reference
Immediate family 0.05 (0.09 to 0.01) 0.11
Nurses providing home care 0.06 (0.11 to 0.02) 0.04
Health insurance companies 0.43 (0.52 to 0.34) <.001
Private sector pharmaceutical companies 0.82 (0.99 to 0.64) <.001
Academic researchers (if your name is
not connected to the data)
0.53 (0.66 to 0.40) <.001
Cost
HH income less than E500 0.0042 (0.0050 to 0.0034) 0.00
HH income from E500 to E1500 0.0036 (0.0043 to 0.0029) 0.00
HH income from E1500 to E3000 0.0031 (0.0037 to 0.0025) 0.00
HH income from E3000 to E9000 0.0028 (0.0033 to 0.0023) 0.00
HH income greater than E9000 0.0016 (0.0029 to 0.0003) 0.20
Missing income 0.0044 (0.0053 to 0.0035) 0.00
aIn all analyses, differences in preferences for each country, age
group, and gender were tested. Where differences did occur, the
group was modelled separately for that particular preference. These
are given in Table 4. The coefficients in this table can therefore be in-
terpreted as the preferences in all other countries, or groups not cov-
ered by the effects given in Table 4.
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Table 4: Preference choice modelling results (summary of differences by country, age and gender)
Model parameter Differences by country Differences by age and gender
Stronger preference or
weaker aversion com-
pared with the baseline
groupa
Weaker preference or
stronger aversion com-
pared with the baseline
groupa
Stronger preference or
weaker aversion com-
pared with the baseline
groupa (coefficient)
Weaker preference or
stronger aversion com-
pared with the baseline
groupa (coefficient)
Information stored
Basic health status Czech Republic (0.19) United Kingdom (0.11) 18–24 (0.28)
Lithuania (0.25)
[information above þ] identification 18–24 (0.23)
[information above þ] lifelong health conditions 18–24 (0.29) 55–64 (0.09)
25–34 (0.10)
[information above þ] all other health
conditions and medical history
Cyprus (0.72) Men (0.06)
18–24 (0.42)
25–34 (0.18)
Access (personnel)
Only doctors and nurses Slovenia (0.30)
Doctors, nurses, and paramedics Estonia (0.24)
Doctors, nurses, paramedics, and fire and rescue Denmark (0.11) 65þ (0.11)
Access (location)
Only in the home country Czech Republic (0.18) Belgium (0.25) 65þ(0.13)
Slovakia (0.11) Ireland (0.19)
Romania (0.34)
Spain (0.25)
Across Europe (EU) Austria (0.21)
Worldwide Slovakia (0.10) 18–24 (0.11) 65þ (0.098)
25–34 (0.14)
Sharing
No one Austria (0.21) Lithuania (0.43)
Luxembourg (0.21) Romania (0.39)
Netherlands (0.27) Slovakia (0.19)
Immediate family Slovenia (0.52)
Nurses providing home care Belgium (0.17) Bulgaria (0.24)
Slovakia (0.27)
France (0.21) Lithuania (0.31)
Health insurance companies Czech Republic (0.20) France (0.40)
Latvia (0.36) Greece (–0.53)
Slovakia (0.19) Italy (0.29)
Hungary (0.22)
Ireland (0.24)
UK (0.25)
Private sector pharmaceutical companies Bulgaria (0.35) Austria (0.23)
Hungary (0.41) Belgium (0.20)
Latvia (0.47) Denmark (0.14)
Lithuania (0.22) Estonia (0.25)
Portugal (0.36) Germany (0.47)
Romania (0.46) Luxembourg (1.56)
Slovakia (0.21) Slovenia (0.32)
Academic researchers (if your name
is not connected to the data)
Estonia (0.36) Romania (0.23)
Denmark (0.33)
aIn all analyses, differences in preferences for each country, age group, and gender were tested. Where differences did occur, the group was mod-
elled separately for that particular preference and these differences are presented in this table.
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cell research, and this may have led to some degree of public accep-
tance of these approaches. There are strong concerns that anonymized
patient records can be uniquely identified,48 and there have been re-
ported high-profile lapses in security for electronic health informa-
tion16,49 (along with findings from this work that health care providers
are not perceived as successful in preventing unauthorized access) and
technology failures.50,51 Strong regulatory frameworks and effective
sanctions where best practices are not in place are relatively weak in
the context of electronic health data sharing.49,52 Development, how-
ever, is not simple; for example, in the context of rapidly developing
technology, it can often be unclear what regulations should cover.53
CONCLUSIONS
In this large objective pan-European stated preference study, respon-
dents gave a range of preferences regarding health information, stor-
age access, and sharing, indicating a nuanced understanding of
privacy. This work clarifies and explains previously inconsistent evi-
dence regarding public perceptions toward privacy, particularly how
the risks to privacy in electronic data storage are understood in the
context of perceived individual and collective benefits. Access to and
sharing of health information beyond those who are involved in imme-
diate care is perceived negatively. When developing frameworks for
the use of electronic health data in this rapidly developing field, assur-
ances of accountability and conditionality, and clear descriptions of
the benefits to individuals, will be required by policy-makers in further
digitization of health information.
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